|
|
|
Insider
Information: |
Davis Stephen |
Relationship: |
Director |
City: |
Branford |
State: |
CT |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
344,117 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,595,864 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
344,117 |
|
|
Total
Value |
$2,595,864 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
16
|
Stock
price went up :
|
0
|
7
|
Stock
price went down : |
0
|
9
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-98.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Heron Therapeutics Inc |
HRTX |
Director |
2022-12-16 |
52,032 |
2010-02-17 |
0 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
EVP & COO |
2012-06-19 |
0 |
2010-04-06 |
0 |
Premium* |
|
Furiex Pharmaceuticals, Inc. |
FURX |
Director |
2014-07-02 |
0 |
2013-05-24 |
0 |
Premium* |
|
Acadia Pharmaceuticals Inc |
ACAD |
|
2024-05-02 |
155,231 |
2019-10-09 |
0 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
Director |
2023-01-03 |
136,854 |
2022-01-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
95 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2019-10-09 |
4 |
OE |
$19.65 |
$585,413 |
D/D |
29,792 |
29,792 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2019-10-10 |
4 |
OE |
$19.65 |
$2,362,087 |
D/D |
120,208 |
120,208 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2019-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,937 |
5,937 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2019-12-05 |
4 |
OE |
$19.65 |
$2,947,500 |
D/D |
150,000 |
152,954 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2020-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,625 |
18,579 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2020-05-13 |
4 |
OE |
$19.65 |
$2,190,150 |
D/D |
111,458 |
123,267 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2020-05-14 |
4 |
OE |
$19.65 |
$1,739,850 |
D/D |
88,542 |
100,351 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2020-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,937 |
17,746 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2021-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,527 |
27,966 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2021-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,625 |
57,162 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2021-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,938 |
55,869 |
0 |
- |
|
BLCM |
Bellicum Pharmaceuticals,... |
Director |
|
2022-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,715 |
18,715 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2022-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,527 |
62,434 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2022-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,945 |
69,661 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2022-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,625 |
81,358 |
0 |
- |
|
BLCM |
Bellicum Pharmaceuticals,... |
Director |
|
2022-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
43,400 |
62,115 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2022-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,938 |
81,813 |
0 |
- |
|
BLCM |
Bellicum Pharmaceuticals,... |
Director |
|
2023-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
74,739 |
136,854 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2023-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,528 |
88,537 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2023-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,945 |
95,578 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2023-04-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,333 |
109,060 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2023-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,625 |
116,103 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2023-07-14 |
4 |
OE |
$20.77 |
$2,077,000 |
D/D |
100,000 |
136,695 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2023-10-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
103,999 |
140,694 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2024-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,528 |
100,253 |
0 |
- |
|
95 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|